孙耀庭于2017年12月加入蛋白质组大数据实验室，主要研究方向为临床蛋白质组学与人工智能交叉方向。
博士研究生在读期间的主要研究内容为“基于蛋白质组学与神经网络对甲状腺结节的精准诊断”。本研究首次通过国际多中心临床大队列样本的蛋白质组学图谱与人工智能手段结合，对甲状腺结节的良恶性进行精准判别。该研究是目前世界上最大规模的组织蛋白质组学研究。新冠疫情期间，主导或参与的新冠相关研究4项，以并列第一作者在Cell、Computational and Structural Biotechnology杂志发表文章2篇。博士研究生阶段曾获得“博士研究生国家奖学金”、“苏武奖学金”、“义翘神州奖学金”、“优秀研究生”、“三好学生”、“优秀研究生干部”等奖学金及荣誉称号。

代表性论文：

1. Yaoting Sun#, Sathiyamoorthy Selvarajan#, Zelin Zang#, Wei Liu#, Yi Zhu#, Hao Zhang#, Hao Chen, Xue Cai, Huanhuan Gao, Zhicheng Wu, Lirong Chen, Xiaodong Teng, Yongfu Zhao, Sangeeta Mantoo, Tony Kiat-Hon Lim, Bhuvaneswari Hariraman, Serene Yeow, Syed Muhammad Fahmy Syed Abdillah, Sze Sing Lee, Guan Ruan, Qiushi Zhang, Tiansheng Zhu, Weibin Wang, Guangzhi Wang, Junhong Xiao, Yi He, Zhihong Wang, Wei Sun, Yuan Qin, Qi Xiao, Xu Zheng, Linyan Wang, Xi Zheng, Kailun Xu, Yingkuan Shao, Kexin Liu, Shu Zheng, Ruedi Aebersold, Stan Z. Li*, Oi Lian Kon*, N. Gopalakrishna Iyer*, Tiannan Guo*.  Protein Classifier for Thyroid Nodules Learned from Rapidly Acquired Proteotypes.2020. MedRxived (Representative Publication)
2.Bo Shen #, Xiao Yi #, Yaoting Sun #, Xiaojie Bi #, Juping Du #, Chao Zhang #, Sheng Quan #, et al, Yi Judy Zhu *, Huafen Liu *, Haixiao Chen *, Tiannan Guo *.Proteomic and Metabolomic Characterization of COVID-19 Patient Sera. Cell. 2020.182(1): 59-72.

3. TiannanGuo*#, Augustin Luna#, Ching Chiek Koh#,Vinodh Rajapakse#, Zhicheng Wu, Michael Patrick Menden, Wei Liu, YaotingSun, Yongran Cheng, Laurence Calzone, Loredana Martignetti, Alessandro Ori,Murat Iskar, Ludovic Gillet, Qing Zhong, Sudhir Varma, Uwe Schmitt, Peng Qiu,Yi Zhu, Kexin Liu, Peter Wild, Garnett Mathew, Peer Bork, Martin Beck, JulioSaez-Rodriguez, William Reinhold, Chris Sander, Yves Pommier*, RuediAebersold*. Quantitative proteome landscape of the NCI-60 cancer celllines.iScience. 2019. 21:664-680.
4. YiZhu#, Jiang Zhu#, Cong Lu, Qiushi Zhang, Wei Xie, PingSun, Xiaochuan Dong, Liang Yue, Yaoting Sun, Xiao Yi, Tiansheng Zhu,Guan Ruan, Ruedi Aebersold*, Shiang Huang*, Tiannan Guo*,Identificationof protein abundance changes in biopsy-level hepatocellular carcinoma tissuesusing PCT-SWATH. Proteomics Clinical Applications. 2019Jan;13(1): e1700179
5. MengXu#, Jingwen Deng#, Kaikun Xu#, Tiansheng Zhu#,Ling Han, Wang Dan, Yaoting Sun, Cheng Chang, Xiaomei Zhang, Jiayu Dai,Liang Yue, Qiushi Zhang, Xue Cai, Yi Zhu, Hu Duan, Yuan Liu, Dong Li, YunpingZhu, Timothy R. D. J. Radstake, Deepak M.W. Balak, Danke Xu*,Tiannan Guo*, Chuanjian Lu* and Xiaobo Yu*.In-depth SerumProteomics Reveals Biomarkers of Psoriasis Severity and Response to TraditionalChinese Medicine. Theranostics. 2019; 9(9):2475-2488.
6. Tiansheng Zhu#, Yi Zhu#*,Yue Xuan#, Huanhuan Gao, Xue Cai, Sander R. Piersma, Thang V. Pham,Tim Schelfhorst, Richard R Goeij De Haas, Irene V. Bijnsdorp, Rui Sun, LiangYue, Guan Ruan, Qiushi Zhang, Mo Hu, Yue Zhou, Winan J. Van Houdt, T.Y.SLelarge, J. Cloos, Anna Wojtuszkiewicz, Danijela Koppers-Lalic, FranziskaBöttger, Chantal Scheepbouwer, R.H Brakenhoff, G.J.L.H. van Leenders, Jan N.M.Ijzermans, J.W.M. Martens, R.D.M. Steenbergen, N.C. Grieken, SathiyamoorthySelvarajan, Sangeeta Mantoo, Sze Sing Lee, Serene Jie Yi Yeow, Syed MuhammadFahmy Alkaff1, Nan Xiang, Yaoting Sun, Xiao Yi, Shaozheng Dai, Wei Liu,Tian Lu, Zhicheng Wu, Xiao Liang, Man Wang, Yingkuan Shao, Xi Zheng, Kailun Xu,Qin Yang, Yifan Meng, Cong Lu, Jiang Zhu, Jin’e Zheng, Bo Wang, Sai Lou, YibeiDai, Chao Xu, Chenhuan Yu, Huazhong Ying, Tony Kiat-hon Lim, Jianmin Wu,Xiaofei Gao, Zhongzhi Luan, Xiaodong Teng, Peng Wu, Shi’ang Huang, Zhihua Tao,N. Gopalakrishna Iyer, Shuigeng Zhou, Wenguang Shao, Henry Lam, Ding Ma, JiafuJi, Oi Lian Kon, Shu Zheng, Ruedi 16 Aebersold, Connie R. Jimene, Tiannan Guo*.DPHL: A pan-humanprotein mass spectrometry library for robust biomarker 1 discovery usingData-Independent Acquisition and Parallel Reaction Monitoring. Genomics,Proteomics and Bioinformatics. https://www.biorxiv.org/content/10.1101/2020.02.03.931329v1
7. YaotingSun, Wei Liu, Changyuan Wang, Qiang Meng, Zhihao Liu, Xiaokui Huo, Xiaobo Yang, Pengyuan Sun, Huijun Sun, Xiaodong Ma, Jinyong Peng, and Kexin Liu. Combination of dihydromyricetin and ondansetron strengthensantiproliferative efficiency of adriamycin in K562/ADR through down regulationof SORCIN: A new strategy of inhibiting P-glycoprotein. Journal of Cellular Physiology. 2019Apr;234(4):3685-3696.
8. YaotingSun, Changyuan Wang, Qiang Meng, Zhihao Liu, Xiaokui Huo, Pengyuan Sun, Huijun Sun, Xiaodong Ma, Jinyong Peng, Kexin Liu. Targeting P-glycoprotein and SORCIN: Dihydromyricetin strengthensanti-proliferative efficiency of adriamycin via MAPK/ERK and Ca2+- mediatedapoptosis mediatedapoptosis pathways in MCF-7/ADR and K562/ADR.   Journal of CellularPhysiology. 2017; Apr;233(4):3066-3079.
9. Wei Liu, Qiang Meng, Yaoting Sun,Changyuan Wang, Xiaokui Huo, Zhihao Liu, Pengyuan Sun, Huijun Sun, Xiaodong Ma, and Kexin Liu. Targeting P-Glycoprotein:Nelfinavir Reverses Adriamycin Resistance inK562/ADR Cells. Cellular Physiologyand Biochemistry.2018;51(4):1616-1631.
10. Changyuan Wang, Zhihao Liu, Yaoting Sun, Ting Chen, Xiaokui Huo, Qiang Meng, Qi Liu, Huijun Sun, Pengyuan Sun, Jinyong Peng, Xiaodong Ma, and Kexin Liu. Astronger reversal effect of the combination of dasatinib and menadioneonP-gp-mediated multidrug resistance in human leukemia K562/Adr cell line. RSC Advances. 2017; 7,17227-17235.
11. Chaojun Xue, Changyuan Wang, Yaoting Sun,Qiang Meng, Zhihao Liu, Xiaokui Huo, Pengyuan Sun, Huijun Sun, Xiaodong Ma, Xiaochi Ma, Jinyong Peng, and Kexin Liu. TargetingP-glycoproteinfunction, p53 and energy metabolism: Combination of metformin and2-deoxyglucose reverses the multidrug resistance of MCF-7/Dox cellstodoxorubicin. Oncotarget. 2016, 8(5):8622-8632